Summary of Significant Accounting Policies - Revenue Recognition (Details)	3 Months Ended
	Mar. 31, 2024 USD ($) item agreement	Mar. 31, 2023 USD ($)
Disaggregation of Product Revenue
Number of distribution agreements | agreement	2
Mytesi
Disaggregation of Product Revenue
Product revenue	$ 2,300,000	$ 1,900,000
Number of specialty pharmacies. | item	5
Mytesi | Specialty Pharmacies
Disaggregation of Product Revenue
Product revenue	$ 2,000,000.0	1,500,000
Canalevia-CA1
Disaggregation of Product Revenue
Product revenue	40,000	28,000
Neonorm
Disaggregation of Product Revenue
Product revenue	$ 9,000	$ 18,000